A unique 10-digit, 3-segment numeric identifier assigned to medications and therapeutic products, providing a standardized code for identification and billing purposes.
The first segment of the NDC representing the manufacturer or distributor of a drug product, assigned by the U.S. Food and Drug Administration (FDA).
The second segment of the NDC indicating the specific drug formulation, strength, and dosage form, distinguishing different versions of a drug marketed by the same manufacturer.
The third segment of the NDC identifying the package size and type of packaging for a specific drug product, helping differentiate various packaging presentations of the same medication.
The federal agency responsible for protecting and promoting public health, overseeing the approval, safety, and labeling of drugs, including the assignment of NDCs.
The categorization of drugs based on their therapeutic use, chemical structure, or mechanism of action, providing a framework for understanding and organizing medications.
A standardized nomenclature for clinical drugs, providing names and codes to enhance interoperability and exchange of drug information in electronic health records, linked with NDC.
A non-proprietary, unique code assigned to active ingredients in drugs, facilitating the identification and tracking of specific components in medication formulations.
A standardized identifier used in healthcare supply chain management to track and trace pharmaceutical products, helping improve efficiency and reduce errors.
Automated systems used in healthcare settings for dispensing medications to patients, often integrated with NDC information for accurate and secure medication administration.